Literature DB >> 3930861

Plasma selenium levels in treated phenylketonuric patients.

A Rottoli, G Lista, G Zecchini, C Butté, R Longhi.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 3930861     DOI： 10.1007/bf01811491

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  3 in total

1.  Selenium content of food consumed by Canadians.

Authors:  J N Thompson; P Erdody; D C Smith
Journal:  J Nutr       Date:  1975-03       Impact factor: 4.798

2.  Zinc and copper status of treated children with phenylketonuria.

Authors:  P B Acosta; P M Fernhoff; H S Warshaw; K M Hambidge; A Ernest; E R McCabe; L J Elsas
Journal:  JPEN J Parenter Enteral Nutr       Date:  1981 Sep-Oct       Impact factor: 4.016

3.  The selenium state of children. II. Selenium content of serum, whole blood, hair and the activity of erythrocyte glutathione peroxidase in dietetically treated patients with phenylketonuria and maple-syrup-urine disease.

Authors:  I Lombeck; K Kasperek; H D Harbisch; K Becker; E Schumann; W Schröter; L E Feinendegen; H J Bremer
Journal:  Eur J Pediatr       Date:  1978-07-19       Impact factor: 3.183
  3 in total
  9 in total

Review 1.  Oxidative stress in phenylketonuria: what is the evidence?

Authors:  Graziela S Ribas; Angela Sitta; Moacir Wajner; Carmen R Vargas
Journal:  Cell Mol Neurobiol       Date:  2011-04-23       Impact factor: 5.046

2.  Decreased selenium intake and low plasma selenium concentrations leading to clinical symptoms in a child with propionic acidaemia.

Authors:  S Yannicelli; K M Hambidge; M F Picciano
Journal:  J Inherit Metab Dis       Date:  1992       Impact factor: 4.982

3.  In vitro OKT3-induced mitogenesis in selenium-deficient patients on a diet for phenylketonuria.

Authors:  R J Collins; P J Boyle; A E Clague; A E Barr; S C Latham
Journal:  Biol Trace Elem Res       Date:  1991-09       Impact factor: 3.738

4.  Trace elements nutriture in hyperphenylalaninemic patients. Long-term follow up study.

Authors:  R Longhi; A Rottoli; A Vittorelli; G Zecchini; T Bonabitacola; F Bertassi; E Riva; M Giovannini
Journal:  Eur J Pediatr       Date:  1987       Impact factor: 3.183

5.  Investigation of oxidative stress parameters in treated phenylketonuric patients.

Authors:  A Sitta; A G Barschak; M Deon; T Terroso; R Pires; R Giugliani; C S Dutra-Filho; M Wajner; C R Vargas
Journal:  Metab Brain Dis       Date:  2006-12-05       Impact factor: 3.584

6.  Effect of docosahexaenoic acid administration on plasma lipid profile and metabolic parameters of children with methylmalonic acidaemia.

Authors:  L Aldámiz-Echevarría; P Sanjurjo; J Elorz; J A Prieto; C Pérez; F Andrade; J Rodríguez-Soriano
Journal:  J Inherit Metab Dis       Date:  2006-02       Impact factor: 4.982

7.  Inborn errors of metabolism with a protein-restricted diet: effect on polyunsaturated fatty acids.

Authors:  P Sanjurjo; J I Ruiz; M Montejo
Journal:  J Inherit Metab Dis       Date:  1997-11       Impact factor: 4.982

8.  Selenium status in infants and children with phenylketonuria and in maternal phenylketonuria.

Authors:  I Lombeck; F Jochum; K Terwolbeck
Journal:  Eur J Pediatr       Date:  1996-07       Impact factor: 3.183

9.  Effect of selenium supplementation on the distribution of selenium among plasma proteins of a patient with maple syrup urine disease.

Authors:  M Borglund; S Sjöblad; B Akesson
Journal:  Eur J Pediatr       Date:  1989-08       Impact factor: 3.183
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.